Infectious disease
HCV NS3 1373–1380 (HLA-B*51:01) IPFYGKAI
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP11230_1
Description
IPFYGKAI is a linear peptidic epitope (epitope ID27847) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays
TechData
| Sequence: | IPFYGKAI |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Genome polyprotein |
| Species: | Hepatitis C virus (HCV) |
| Allele: | HLA-B*51:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |